Anika to Issue Second Quarter 2022 Financial Results on Wednesday, August 3, 2022

Rhea-AI Summary

Anika Therapeutics, Inc. (NASDAQ: ANIK) announced plans to release its Q2 2022 financial results after the market close on August 3, 2022. The company will also hold an investor conference call at 5:00 p.m. ET on the same day to discuss financial results and business highlights. Investors can access the call by dialing 1-888-220-8474 or via a live audio webcast available on Anika's website. The company specializes in joint preservation and minimally invasive orthopedic solutions, focusing on osteoarthritis management and sports medicine.

Positive

• Scheduled Q2 2022 financial results announcement may indicate future growth.
• Investor call on August 3 allows direct engagement with shareholders.

Negative

• None.

BEDFORD, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its second quarter 2022 financial results after the close of the market on Wednesday, August 3, 2022 and hold its investor conference call on the same day, at 5:00 p.m. ET to discuss its financial results and business highlights.

The conference call can be accessed by dialing 1-888-220-8474 (toll-free domestic) or 1-856-344-9221 (international) and providing the conference ID number 1507585. A live audio webcast will be available in the Investor Relations section of Anika's website, www.anika.com. An accompanying slide presentation also can be accessed via the Anika website. The call will be archived and accessible on the same website shortly after its conclusion.

About Anika
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Leveraging our core expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide minimally invasive products that restore active living for people around the world. Our focus is on high opportunity spaces within orthopedics, including osteoarthritis pain management, regenerative solutions, sports medicine soft tissue repair and bone preserving joint technologies, and our products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika’s global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com.

ANIKA, ANIKA THERAPEUTICS and the Anika logo are registered trademarks of Anika Therapeutics, Inc.

For Investor Inquiries:
Anika Therapeutics, Inc.
Mark Namaroff, 781-457-9287
Vice President, Investor Relations, ESG and Corporate Communications
investorrelations@anika.com

FAQ

When will Anika Therapeutics announce its Q2 2022 financial results?

Anika Therapeutics will announce its Q2 2022 financial results on August 3, 2022.

What time is the Anika Therapeutics investor conference call?

The investor conference call is scheduled for 5:00 p.m. ET on August 3, 2022.

How can I access the Anika Therapeutics investor conference call?

You can access the conference call by dialing 1-888-220-8474 or through a live audio webcast on Anika's website.

What is the focus of Anika Therapeutics?

Anika Therapeutics specializes in joint preservation and minimally invasive orthopedic care, particularly in osteoarthritis management and sports medicine.